Senior Director, Global Medical Affairs – Pulmonary Hypertension

ResponsibilitiesDrives execution of the annual V&I plan with medical affairs colleagues from key countries and regions including U.S.Acts as an empowered partner, making informed decisions with a strategic and agile mindset.Serves as the SME and connector across assigned therapeutic areas, translating global scientific platforms into actionable Medical Value Narratives (MVNs).Actively engages with country-level stakeholders—including medical advisors, payers, and scientific leaders—to ensure strategic alignment and support local data generation, congress planning, and advisory boards.Serves as the medical representative within Product Development sub-teams (including Clinical, V&I, Commercial, Publications, and Label), leveraging the V&I GMSA vision to drive strategic planning, outcome delivery, and tactical execution.Communicates pertinent information to stakeholders to inform and influence country and regional planning.Acts as the subject‑matter expert, collaborating closely with V&I Outcomes Research, Policy, Commercial, and Market Access teams to identify and address opportunities and barriers in key countries.Serves as a strategic partner for Big Country Markets (U.S., China, Japan) with no RDMA role.Plays a pivotal role in bridging global strategy with local execution.Proactively collaborates with the US DMA and equivalent roles in China and Japan.Consolidates actionable medical insights from countries and regions.Engages with a network of international scientific leaders and other key stakeholders.Monitors external changing environment in partnership with the competitive intelligence (CI) team.Organizes global expert‑input events (advisory boards and expert‑input forums).Collaborates with Global Human Health (commercial) executive directors to inform of the GMSA portion of V&I plans to ensure alignment.Organizes global symposia and medical educational meetings.Supports key countries with the development of local data‑generation study concepts and protocols when requested.Reviews Investigator‑Initiated Study proposals from key countries (ex‑U.S.) prior to headquarters submission.Manages programs (patient support, educational or risk management) to support appropriate and safe utilization of medicines.Demonstrates and champions our company’s Ways of Working, emphasizing innovation and focusing on the impact to the patient.Manages assigned budget with strong financial stewardship, ensuring delivery within a 3% variance.RequirementsMinimum M.D., Ph.D. or Pharm.D. (M.D. preferred) and recognized medical expertise in Pulmonary Hypertension space.Minimum 5 years experience in pulmonary hypertension.Experience in country/region or global medical affairs or clinical development.Strong prioritization and decision‑making skills.Strategic thinking skills and broad understanding of therapeutic area, scientific knowledge.Ability to effectively collaborate with partners across divisions in a matrix environment.Excellent interpersonal, analytical, and communication skills (written and oral) in addition to results‑oriented project management skills. #J-18808-Ljbffr